Mechanistic studies of tumor-associated macrophage immunotherapy

被引:3
|
作者
Cao, Jiandong [1 ,2 ]
Liu, Chengsen [3 ]
机构
[1] Shenyang Chest Hosp, Dept Thorac Surg, Shenyang, Liaoning, Peoples R China
[2] Tenth Peoples Hosp, Shenyang, Liaoning, Peoples R China
[3] Peoples Hosp Liaoning Prov, Dept Radiotherapy, Shenyang, Liaoning, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2024年 / 15卷
关键词
tumor-associated macrophages; TAMs; tumor microenvironment; immunotherapy; cancer; COLONY-STIMULATING FACTOR; CANCER; RECEPTOR; POLARIZATION; ACTIVATION; EXPRESSION; BLOCKADE; CELLS; PROGRESSION; METASTASIS;
D O I
10.3389/fimmu.2024.1476565
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Tumor-associated macrophages (TAMs) are present in the tumor microenvironment and can polarize into subtypes with different functions and characteristics in response to different stimuli, classifying them into anti-tumorigenic M1-type and pro-tumorigenic M2-type. The M1-type macrophages inhibit tumor growth through the release of pro-inflammatory cytokines, whereas the M2-type macrophages contribute to tumor progression through the promotion of tumor proliferation, angiogenesis and metastasis. Due to the duality of macrophage effects on tumors, TAMs have been a hot topic in tumor research. In this paper, the heterogeneity and plasticity of TAMs, the interactions between TAMs and other immune cells, and the effects of TAMs on tumors are reviewed, and the therapeutic strategies for TAMs are summarized and discussed. These therapeutic strategies encompass methods and approaches to inhibit the recruitment of TAMs, deplete TAMs, and modulate the polarization of TAMs. These studies help to deeply understand the mechanism of TAMs-tumor interaction and provide reference for combination therapy of tumors.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Targeting tumor-associated acidity in cancer immunotherapy
    Ruben Lacroix
    Elisa A. Rozeman
    Marina Kreutz
    Kathrin Renner
    Christian U. Blank
    Cancer Immunology, Immunotherapy, 2018, 67 : 1331 - 1348
  • [42] Tumor extracellular vesicles are required for tumor-associated macrophage programming
    Rabe, Daniel C.
    Lee, Jiyoung
    Rustandy, Felicia
    Rosner, Marsha R.
    CANCER RESEARCH, 2018, 78 (13)
  • [43] Redefining Tumor-Associated Macrophage Subpopulations and Functions in the Tumor Microenvironment
    Wu, Kaiyue
    Lin, Kangjia
    Li, Xiaoyan
    Yuan, Xiangliang
    Xu, Peiqing
    Ni, Peihua
    Xu, Dakang
    FRONTIERS IN IMMUNOLOGY, 2020, 11 : 1731
  • [44] Tumor-associated fibrosis as a regulator of tumor immunity and response to immunotherapy
    Hong Jiang
    Samarth Hegde
    David G. DeNardo
    Cancer Immunology, Immunotherapy, 2017, 66 : 1037 - 1048
  • [45] Targeting immune checkpoints on tumor-associated macrophages in tumor immunotherapy
    Xu, Shumin
    Wang, Chenyang
    Yang, Lingge
    Wu, Jiaji
    Li, Mengshu
    Xiao, Peng
    Xu, Zhiyong
    Xu, Yun
    Wang, Kai
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [46] Tumor-associated fibrosis as a regulator of tumor immunity and response to immunotherapy
    Jiang, Hong
    Hegde, Samarth
    DeNardo, David G.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2017, 66 (08) : 1037 - 1048
  • [47] Metronomic Mild-Temperature Photothermal Therapy Modulating Tumor-Associated Macrophage Repolarization as a Neoadjuvant Immunotherapy
    Yao, Hanye
    Xing, Yixin
    Yin, Yuying
    Xue, Jingqiang
    Yin, Chenlu
    Gu, Wei
    ACS APPLIED NANO MATERIALS, 2024, 7 (19) : 23133 - 23141
  • [48] Tumor-Associated Macrophage Subsets: Shaping Polarization and Targeting
    Zhang, Qindong
    Sioud, Mouldy
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (08)
  • [49] Expression of Tumor-Associated Macrophage in Progression of Human Glioma
    Peng Ding
    Weimin Wang
    Jinkun Wang
    Zhiyong Yang
    Liping Xue
    Cell Biochemistry and Biophysics, 2014, 70 : 1625 - 1631
  • [50] A temporal perspective for tumor-associated macrophage identities and functions
    Bleriot, Camille
    Dunsmore, Garett
    Alonso-Curbelo, Direna
    Ginhoux, Florent
    CANCER CELL, 2024, 42 (05) : 747 - 758